Recent Advances in Systemic and Emerging Mycoses

A special issue of Journal of Fungi (ISSN 2309-608X). This special issue belongs to the section "Fungal Pathogenesis and Disease Control".

Deadline for manuscript submissions: 30 June 2025 | Viewed by 759

Special Issue Editors


E-Mail Website1 Website2
Guest Editor
Institute of Biomedical Sciences, Department of Microbiology, University of Sao Paulo, ICB II-USP, São Paulo, Brazil
Interests: pathogenic dimorphic fungi; fungal virulence; immune response; vaccines and nanovaccines; fungal diagnostics; antifungal activity; mycoses; fungal resistance; endemic and emerging systemic infections; alternative in vivo methods for infection
Special Issues, Collections and Topics in MDPI journals

E-Mail Website1 Website2
Guest Editor
Institute of Biomedical Sciences, Department of Microbiology, University of Sao Paulo, ICB II-USP, São Paulo, Brazil
Interests: fungal infections; fungal virulence; nanotherapy; nanovaccines; antifungal activity; mycoses; fungal resistance; endemic and emerging systemic infections; alternative in vivo methods for infection

Special Issue Information

Dear Colleagues,

Fungal diseases are becoming increasingly common worldwide, especially in developing countries. Endemic and emerging systemic infections have increased dramatically due to the pandemic caused by the Severe Acute Respiratory Syndrome virus (SARS-CoV-2). This increase is a cause for concern among scientists, since the therapeutic arsenal against fungal infections is limited and the number of resistant and multidrug-resistant fungal species is constantly growing. In view of this, much research has developed new treatment options as well as new and promising diagnostic methodologies in order to accelerate the detection and combatting of pathogens. Therefore, this Special Issue aims to bring together new advances in systemic and emerging mycoses, bringing together studies involved in the evaluation of virulence, resistance, new therapies, and diagnosis against fungal pathogens. Studies involving in vitro, in vivo, and alternative in vivo models are highly recommended.

Prof. Dr. Carlos Pelleschi Taborda
Dr. Gabriel Davi Marena
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Fungi is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vaccines and nanovaccines
  • antifungal therapy
  • diagnosis
  • fungal resistance
  • endemic and emerging systemic infections
  • immune response
  • alternative in vivo infection models

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

17 pages, 9451 KiB  
Article
Resistance to Azoles in Candida parapsilosis Isolates from Spain Is Associated with an Impairment in Filamentation and Biofilm Formation
by Alba Torres-Cano, Cristina de Armentia, Alejandra Roldán, Elena López-Peralta, Juliana Manosalva, Paloma Merino-Amador, Fernando González-Romo, Mireia Puig-Asensio, Carmen Ardanuy, María Teresa Martín-Gómez, Daniel Romero-Herrero, Ana Pérez-Ayala, Marta López-Lomba, María Teresa Durán-Valle, Isabel Sánchez-Romero, María Muñoz-Algarra, María Pía Roiz-Mesones, Isabel Lara-Plaza, Maite Ruíz Pérez de Pipaón, Gregoria Megías-Lobón, María Ángeles Mantecón-Vallejo, Laura Alcázar-Fuoli, Diego Megías and Oscar Zaragozaadd Show full author list remove Hide full author list
J. Fungi 2025, 11(4), 299; https://doi.org/10.3390/jof11040299 - 9 Apr 2025
Viewed by 466
Abstract
In recent years, there has been an increase in the incidence of fluconazole-non-susceptible (FNS) Candida parapsilosis. The reasons why these strains are able to colonize hospitals remain unknown. It is also unclear whether these strains exhibit resistance to the disinfectants used in [...] Read more.
In recent years, there has been an increase in the incidence of fluconazole-non-susceptible (FNS) Candida parapsilosis. The reasons why these strains are able to colonize hospitals remain unknown. It is also unclear whether these strains exhibit resistance to the disinfectants used in hospitals, facilitating their spread. For these reasons, in this work, we aimed to investigate whether fluconazole resistance was associated with virulence traits and the resistance of these strains to common hospital disinfectants. The general conclusion of the study was that more than 95% of the FNS strains, regardless of the resistance mutation they carried, had filamentation problems, whereas around 75% of the susceptible strains formed pseudohyphae and were capable of filamentation. This 95% of the FNS strains did not form pseudohyphae, did not invade agar, and did not form biofilms, while the susceptible strains exhibited the opposite behaviour. Through microfluidics experiments, we observed that both the susceptible and FNS strains were capable of adhering to a plastic surface under dynamic conditions, but the FNS strains formed unstable aggregates that did not remain attached to the surface, confirming the filamentation defect of these strains. In the second part of the study, we observed that FNS strains are susceptible to clinical disinfectants, although they presented a slight resistance to some of them, such as chlorhexidine, compared to susceptible isolates. In this work, we address important aspects to understand the dissemination of FNS strains in clinical outbreaks. Full article
(This article belongs to the Special Issue Recent Advances in Systemic and Emerging Mycoses)
Show Figures

Figure 1

Back to TopTop